Difference between revisions of "Team:EPF Lausanne/Timeline"

Line 16: Line 16:
 
     <div class="timeline-section">
 
     <div class="timeline-section">
 
         <ul class="timeline">
 
         <ul class="timeline">
        <li class="timeline-inverted">
 
          <div class="timeline-panel">
 
            <div class="timeline-heading">
 
              <h4 class="timeline-title">Mussum ipsum cacilds</h4>
 
            </div>
 
            <div class="timeline-body">
 
              <p>Mussum ipsum cacilds, vidis litro abertis. Consetis adipiscings elitis. Pra lá , depois divoltis porris, paradis. Paisis, filhis, espiritis santis. Mé faiz elementum girarzis, nisi eros vermeio, in elementis mé pra quem é amistosis quis leo. Manduma pindureta quium dia nois paga. Sapien in monti palavris qui num significa nadis i pareci latim. Interessantiss quisso pudia ce receita de bolis, mais bolis eu num gostis.</p>
 
            </div>
 
          </div>
 
        </li>
 
 
         <li class="timeline-inverted">
 
         <li class="timeline-inverted">
 
           <div class="timeline-badge"></div>
 
           <div class="timeline-badge"></div>
Line 35: Line 25:
 
             <div class="timeline-body">
 
             <div class="timeline-body">
 
               <p>The E. Coli part of our project is strongly based on the paper of Bikard et al. "Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system". Bikard sent us his strains JEN202, JEN202+PWJ89 and DH5A+PWJ66. We also ordered a plasmid containing dCas9 and the synthetic DNA encoding fou our gRNAs.</p>
 
               <p>The E. Coli part of our project is strongly based on the paper of Bikard et al. "Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system". Bikard sent us his strains JEN202, JEN202+PWJ89 and DH5A+PWJ66. We also ordered a plasmid containing dCas9 and the synthetic DNA encoding fou our gRNAs.</p>
               
 
                <hr>
 
              <div class="btn-group">
 
                <button type="button" class="btn btn-primary btn-sm dropdown-toggle" data-toggle="dropdown">
 
                  <i class="glyphicon glyphicon-cog"></i> <span class="caret"></span>
 
                </button>
 
                <ul class="dropdown-menu" role="menu">
 
                  <li><a href="http://nar.oxfordjournals.org/content/41/15/7429.short" target="blank">Bikard et al.</a></li>
 
                </ul>
 
              </div>
 
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 57: Line 37:
 
             <div class="timeline-body">
 
             <div class="timeline-body">
 
               <p>In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated  gRNA sequences on the E. Coli or Yeast genome.</p>
 
               <p>In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated  gRNA sequences on the E. Coli or Yeast genome.</p>
                <hr>
 
                <div class="btn-group">
 
                <button type="button" class="btn btn-primary btn-sm dropdown-toggle" data-toggle="dropdown">
 
                  <i class="glyphicon glyphicon-cog"></i> <span class="caret"></span>
 
                </button>
 
                <ul class="dropdown-menu" role="menu">
 
                  <li><a href="" target="blank">Wiki</a></li>
 
                  <li class="divider"></li>
 
                  <li><a href="" target="blank">Download</a></li>
 
                </ul>
 
              </div>
 
           
 
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 130: Line 98:
 
             <div class="timeline-body">
 
             <div class="timeline-body">
 
               <p>First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.</p>
 
               <p>First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.</p>
               <img src="https://static.igem.org/mediawiki/2015/2/2e/Team_All.jpg" width="750" class="displayed">
+
               <img src="https://static.igem.org/mediawiki/2015/2/2e/Team_All.jpg" width="100%" lass="displayed">
 
             </div>
 
             </div>
 
           </div>
 
           </div>

Revision as of 08:40, 12 August 2015

EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits

Timeline

  • The bible

    The E. Coli part of our project is strongly based on the paper of Bikard et al. "Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system". Bikard sent us his strains JEN202, JEN202+PWJ89 and DH5A+PWJ66. We also ordered a plasmid containing dCas9 and the synthetic DNA encoding fou our gRNAs.

  • Blast

    02.04.2015

    In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated gRNA sequences on the E. Coli or Yeast genome.

  • And the winner is...

    26.03.2015

    ...the new framework for biologic circuits using dCas9.

  • The lab starts!

    24.03.2015 - 26.03.2015

    TAs start to train us in the lab: medium and agar plates preparation

  • Brainstorming finalists

    19.03.2015

    Three cool ideas came out of the brainstorming: a new framework for biologic circuits or lung cancer therapy using dCas9 and cell-cell communication through exosomes.

  • Brainstorming

    26.02.2015 - 12.03.2015

    The team is split into small groups, brainstorming for an interesting project that will occupy us during the summer.

  • First meeting: iGEM officially starts!

    19.02.2015

    First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.

EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits